GR-46611

Pharmaceutical compound From Wikipedia, the free encyclopedia

GR-46611 is a non-selective serotonin 5-HT1 receptor agonist of the triptan group which has been used in scientific research.[1][2][3][4] It is specifically an agonist of the serotonin 5-HT1A, 5-HT1B, and 5-HT1D receptors.[4] The drug's affinities (Ki) are 1.3 nM for the serotonin 5-HT1A receptor, 0.1 to 1.3 nM for the serotonin 5-HT1B receptor, and 0.2 to 1.0 nM for the serotonin 5-HT1D receptor.[3][4][5] Conversely, it showed very weak affinity for the serotonin 5-HT2A receptor (Ki = 1,000 nM).[4] The drug does not alter or stimulate locomotor activity when given alone in rodents, but does potentiate the hyperlocomotion induced by the serotonin 5-HT1A receptor agonists 8-OH-DPAT and buspirone.[2] The chemical synthesis of GR-46611 has been described.[3] GR-46611 was first described in the scientific literature by 1994.[6]

Other namesGR46611
ATC code
  • None
Quick facts Clinical data, Other names ...
GR-46611
Clinical data
Other namesGR46611
Drug classSerotonin 5-HT1 receptor agonist; Serotonin 5-HT1A receptor agonist; Serotonin 5-HT1B receptor agonist; Serotonin 5-HT1D receptor agonist
ATC code
  • None
Identifiers
  • (E)-3-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-[(4-methoxyphenyl)methyl]prop-2-enamide
CAS Number
PubChem CID
ChemSpider
ChEBI
ChEMBL
Chemical and physical data
FormulaC23H27N3O2
Molar mass377.488 g·mol−1
3D model (JSmol)
  • CN(C)CCC1=CNC2=C1C=C(C=C2)/C=C/C(=O)NCC3=CC=C(C=C3)OC
  • InChI=1S/C23H27N3O2/c1-26(2)13-12-19-16-24-22-10-6-17(14-21(19)22)7-11-23(27)25-15-18-4-8-20(28-3)9-5-18/h4-11,14,16,24H,12-13,15H2,1-3H3,(H,25,27)/b11-7+
  • Key:LBVZWEWTNUDWNS-YRNVUSSQSA-N
Close

See also

References

Related Articles

Wikiwand AI